315 related articles for article (PubMed ID: 8709246)
1. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.
Beatty JA; Willett BJ; Gault EA; Jarrett O
J Virol; 1996 Sep; 70(9):6199-206. PubMed ID: 8709246
[TBL] [Abstract][Full Text] [Related]
2. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
[TBL] [Abstract][Full Text] [Related]
3. Retroviral vector-transduced cells expressing the core polyprotein induce feline immunodeficiency virus-specific cytotoxic T-lymphocytes from infected cats.
Li J; Brown WC; Song W; Carpino MR; Wolf AM; Grant CK; Elder JH; Collisson EW
Virus Res; 1995 Oct; 38(2-3):93-109. PubMed ID: 8578869
[TBL] [Abstract][Full Text] [Related]
4. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
Flynn JN; Keating P; Hosie MJ; Mackett M; Stephens EB; Beatty JA; Neil JC; Jarrett O
J Immunol; 1996 Oct; 157(8):3658-65. PubMed ID: 8871667
[TBL] [Abstract][Full Text] [Related]
5. Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.
Flynn JN; Cannon CA; Beatty JA; Mackett M; Rigby MA; Neil JC; Jarrett C
J Virol; 1994 Sep; 68(9):5835-44. PubMed ID: 8057464
[TBL] [Abstract][Full Text] [Related]
6. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
[TBL] [Abstract][Full Text] [Related]
7. Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein.
Song W; Collisson EW; Li J; Wolf AM; Elder JH; Grant CK; Brown WC
Virology; 1995 Jun; 209(2):390-9. PubMed ID: 7778274
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A; Jin X; Sissons P; Borysiewicz L
J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
[TBL] [Abstract][Full Text] [Related]
9. Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.
Toyosaki T; Miyazawa T; Furuya T; Tomonaga K; Shin YS; Okita M; Kawaguchi Y; Kai C; Mori S; Mikami T
Arch Virol; 1993; 131(3-4):335-47. PubMed ID: 8102229
[TBL] [Abstract][Full Text] [Related]
10. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.
Flynn JN; Cannon CA; Neil JC; Jarrett O
J Virol; 1997 Oct; 71(10):7586-92. PubMed ID: 9311839
[TBL] [Abstract][Full Text] [Related]
12. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.
Yang JS; English RV; Ritchey JW; Davidson MG; Wasmoen T; Levy JK; Gebhard DH; Tompkins MB; Tompkins WA
J Virol; 1996 May; 70(5):3011-7. PubMed ID: 8627777
[TBL] [Abstract][Full Text] [Related]
13. Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection.
Burkhard MJ; Mathiason CK; Bowdre T; Hoover EA
AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1767-78. PubMed ID: 11788028
[TBL] [Abstract][Full Text] [Related]
14. Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats.
Song W; Collisson EW; Billingsley PM; Brown WC
J Virol; 1992 Sep; 66(9):5409-17. PubMed ID: 1323704
[TBL] [Abstract][Full Text] [Related]
15. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D
Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250
[TBL] [Abstract][Full Text] [Related]
16. gag- and env-specific serum antibodies in cats after natural and experimental infection with feline immunodeficiency virus.
Rimmelzwaan GF; Siebelink KH; Broos H; Drost GA; Weijer K; van Herwijnen R; Osterhaus AD
Vet Microbiol; 1994 Mar; 39(1-2):153-65. PubMed ID: 8203121
[TBL] [Abstract][Full Text] [Related]
17. Studies on feline CD8+ T cell non-cytolytic anti-feline immunodeficiency virus (FIV) activity.
Hohdatsu T; Miyagawa N; Ohkubo M; Kida K; Koyama H
Arch Virol; 2000; 145(12):2525-38. PubMed ID: 11205103
[TBL] [Abstract][Full Text] [Related]
18. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
19. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
[TBL] [Abstract][Full Text] [Related]
20. Differences in Env and Gag protein expression patterns and epitope availability in feline immunodeficiency virus infected PBMC compared to infected and transfected feline model cell lines.
Roukaerts IDM; Grant CK; Theuns S; Christiaens I; Acar DD; Van Bockstael S; Desmarets LMB; Nauwynck HJ
Virus Res; 2017 Jan; 227():249-260. PubMed ID: 27836726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]